145 Results for "

antipsychotic agent

" in MedChemExpress (MCE) Product Catalog:
Products (145)

145 Results for "antipsychotic agent" in MCE Product Catalog:

147
147 Publications Verification
Cat. No.: HY-12708
CAS No.: 50-53-3
Purity:  99.75%
Chlorpromazine is an orally active, blood-brain barrier-transparent antipsychotic agent that effectively antagonises D2 dopamine receptors and 5-HT2A, which is widely used in schizophrenia and other psychiatric disorders. Chlorpromazine exerts anti-cancer activity through a variety of pathways, including anti-proliferation, induction of autophagy and cycle arrest (G2-M phase), inhibition of cytochrome c oxidase (CcO), inhibition of tumour growth and metastasis, and inhibition of tumour immune escape. Chlorpromazine also blocks hNav1.7 channels (IC50=25.9 μM; concentration-dependent) and HERG potassium channels (IC50=21.6 μM), which has potential for analgesic and cardiac arrhythmic studies. Chlorpromazine also can inhibit clathrin-mediated endocytosis .
loading...
    loading...
147
147 Publications Verification
Cat. No.: HY-B0407A
CAS No.: 69-09-0
Chlorpromazine hydrochloride is an orally active, blood-brain barrier-transparent antipsychotic agent that effectively antagonises D2 dopamine receptors and 5-HT2A, which is widely used in schizophrenia and other psychiatric disorders. Chlorpromazine hydrochloride exerts anti-cancer activity through a variety of pathways, including anti-proliferation, induction of autophagy and cycle arrest (G2-M phase), inhibition of cytochrome c oxidase (CcO), inhibition of tumour growth and metastasis, and inhibition of tumour immune escape. Chlorpromazine hydrochloride also blocks hNav1.7 channels (IC50=25.9 μM; concentration-dependent) and HERG potassium channels (IC50=21.6 μM), which has potential for analgesic and cardiac arrhythmic studies. Chlorpromazine hydrochloride also can inhibit clathrin-mediated endocytosis .
loading...
    loading...
22
22 Cited Publications
Cat. No.: HY-14538
CAS No.: 52-86-8
Purity:  99.73%
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease Cancer

Haloperidol is a potent dopamine D2 receptor antagonist, widely used as an antipsychotic agent. Haloperidol can be used in the study of schizophrenia, tics in Tourette syndrome, mania in bipolar disorder, delirium, agitation, acute psychosis, and hallucinations from alcohol withdrawal.
loading...
    loading...
22
22 Cited Publications
Cat. No.: HY-14538B
CAS No.: 53515-91-6
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease Cancer

Haloperidol lactate is a potent antipsychotic agent. Haloperidol lactate can be used in acute and chronic schizophrenia and gilles de la tourette's syndrome. Haloperidol lactate has the potential for the research of psychotic disorders .
loading...
    loading...
22
22 Cited Publications
Cat. No.: HY-14538A
CAS No.: 1511-16-6
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease Cancer

Haloperidol hydrochloride is a potent dopamine D2 receptor antagonist, widely used as an antipsychotic agent. Haloperidol hydrochloride can be used in the study of schizophrenia, tics in Tourette syndrome, mania in bipolar disorder, delirium, agitation, acute psychosis, and hallucinations from alcohol withdrawal.
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-B1019
CAS No.: 15676-16-1
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

Sulpiride is an orally active dopamine D2/D3 receptor antagonist. Sulpiride is an atypical antipsychotic agent of the benzamide family. Sulpiride can be used in research into anxiety, depression and breast cancer .
loading...
    loading...
11
11 Cited Publications
Cat. No.: HY-136109
CAS No.: 1310422-41-3
Purity:  99.89%
Synonyms: SEP-363856 hydrochloride; SEP-856 hydrochloride
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

SEP-363856 (SEP-856) hydrochloride, an orally active TAAR1 and 5-HT1A agonist and CNS active psychotropic agent with a unique, non-D2/5-HT2A mechanism of action, exerts its antipsychotic-like effects. SEP-363856 hydrochloride has the potential for the study of schizophrenia .
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-B0532
CAS No.: 117-89-5
Trifluoperazine, an antipsychotic agent, acts by blocking central dopamine receptors. Trifluoperazine is a potent α1-adrenergic receptor antagonist. Trifluoperazine is a potent NUPR1 inhibitor exerting anticancer activity. Trifluoperazine is a calmodulin inhibitor, and also inhibits P-glycoprotein. Trifluoperazine can be used for the research of schizophrenia. Trifluoperazine acts as a reversible inhibitor of influenza virus morphogenesis .
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-B0532A
CAS No.: 440-17-5
Trifluoperazine dihydrochloride, an antipsychotic agent, acts by blocking central dopamine receptors. Trifluoperazine dihydrochloride is a potent α1-adrenergic receptor antagonist. Trifluoperazine dihydrochloride is a potent NUPR1 inhibitor exerting anticancer activity. Trifluoperazine dihydrochloride is a calmodulin inhibitor, and also inhibits P-glycoprotein. Trifluoperazine dihydrochloride can be used for the research of schizophrenia. Trifluoperazine dihydrochloride acts as a reversible inhibitor of influenza virus morphogenesis .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-B1077
CAS No.: 26864-56-2
Synonyms: R-16341
Penfluridol (R-16341) is a potent, long-acting, first-generation, oral diphenylbutylpiperidine antipsychotic agent by targeting D2-like dopamine receptor. Penfluridol effectively inhibits TNFα-induced NF-κB activation and alleviates the severity of arthritis and colitis in vivo. Penfluridol is a Ca2+-calmodulin inhibitor. Penfluridol induces apoptosis and autophagy. Penfluridol is used for chronic schizophrenia, acute psychosis, Tourette syndrome and autoimmune diseases. Penfluridol inhibites the growth of E. faecalis planktonic cells with the MIC of 7.81 μg/ml .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-14763
CAS No.: 839712-12-8
Purity:  99.83%
Synonyms: RGH-188
Research Areas:  

Neurological Disease

Cariprazine is a novel antipsychotic agent candidate that exhibits high affinity for the D3 (Ki=0.085 nM) and D2 (Ki=0.49 nM) receptors, and moderate affinity for the 5-HT1A receptor (Ki=2.6 nM).
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-14763A
CAS No.: 1083076-69-0
Purity:  99.90%
Synonyms: RGH188 hydrochloride
Research Areas:  

Neurological Disease

Cariprazine hydrochloride is a novel antipsychotic agent candidate that exhibits high affinity for the D3 (Ki=0.085 nM) and D2 (Ki=0.49 nM) receptors, and moderate affinity for the 5-HT1A receptor (Ki=2.6 nM).
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-12505
CAS No.: 215923-54-9
Purity:  99.62%
Target:  

iGluR Autophagy

Research Areas:  

Neurological Disease

CX546 is a first-generation and selective benzamide-type positive AMPAR modulator. CX546 is a prototypical ampakine agent and has antipsychotic effects .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-15780
CAS No.: 913611-97-9
Purity:  99.64%
Synonyms: OPC-34712
Brexpiprazole (OPC-34712), an atypical orally active antipsychotic agent, is a partial agonist of human 5-HT1A and dopamine D2L receptor with Kis of 0.12 nM and 0.3 nM, respectively. Brexpiprazole is also a 5-HT2A receptor antagonist with a Ki of 0.47 nM. Brexpiprazole also shows potent antagonist activity at human noradrenergic α1B (Ki=0.17 nM) and α2C receptors (Ki=0.59 nM) .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-14542
CAS No.: 146939-27-7
Purity:  99.81%
Synonyms: CP-88059
Research Areas:  

Neurological Disease

Ziprasidone (CP-88059), an orally active antipsychotic agent, is a combined 5-HT and dopamine receptor antagonist . Ziprasidone mesylate trihydrate has affinities for Rat D2 (Ki=4.8 nM), 5-HT2A (Ki=0.42 nM) and 5-HT1A (Ki=3.4 nM) .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-17407
CAS No.: 138982-67-9
Synonyms: CP 88059 hydrochloride monohydrate
Research Areas:  

Neurological Disease

Ziprasidone (CP-88059) hydrochloride monohydrate is an orally active combined 5-HT and dopamine receptor antagonist . Ziprasidone hydrochloride monohydrate has affinities for Rat D2 (Ki=4.8 nM), 5-HT2A (Ki=0.42 nM) and 5-HT1A (Ki=3.4 nM) .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-A0019
CAS No.: 144598-75-4
Synonyms: 9-Hydroxyrisperidone
Paliperidone (9-Hydroxyrisperidone), the major active metabolite of Risperidone, is a dopamine D2 antagonist and 5-HT2A antagonist. Paliperidone is also active as an antagonist at α1 and α2 adrenergic receptors and H1-histaminergic receptors. Paliperidone, a antipsychotic agent, shows efficacy against schizophrenia .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-B1655
CAS No.: 1841-19-6
Synonyms: R 6218; Redeptin
Target:  

Calcium Channel

Research Areas:  

Neurological Disease

Fluspirilene is a non-competitive antagonist of L-type calcium channels with an IC50 of 0.03 μM. Fluspirileneis a long-acting injectable depot antipsychotic agent used for schizophrenia.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-A0151
CAS No.: 316-81-4
Synonyms: RP 7843; SKF 5883; Thioperazine
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

Thioproperazine (RP 7843) is an orally active antipsychotic agent with calming, antiemetic activity. Thioproperazine is effective in promoting the release of dopamine in rat striatum. Thioproperazine can be used in studies of schizophrenia and bipolar disorder .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-13575
CAS No.: 132810-10-7
Purity:  99.62%
Synonyms: AD-5423
Blonanserin (AD-5423) is a potent and orally active 5-HT2A (Ki=0.812 nM) and dopamine D2 receptor (Ki =0.142 nM) antagonist. Blonanserin is usually acts as an atypical antipsychotic agent and can be used for the research of extrapyramidal symptoms, excessive sedation, or hypotension .
loading...
    loading...